Records containing: Stage IV Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-05Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Phase II Open-Label Trial
-
CLINICAL_TRIALS study record update · 2026-02-24A Phase IB Study to Assess the Safety and Efficacy of Neoadjuvant Administration of Autologous Tumor Infiltrating Lymphocytes (LN144/Lifileucel) and Pembrolizumab for Treatment of Patients With Locally Advanced (Stage IIIB-D)/Metastatic (Stage IV) Melanoma
-
CLINICAL_TRIALS study record update · 2026-01-29Optimization of Immunotherapy Treatment for Advanced Melanoma in the Context of the Public Brazilian Health System (OTIMAS)
-
CLINICAL_TRIALS study record update · 2025-08-01Combination of Targeted Therapy (Encorafenib and Binimetinib) Followed by Combination of Immunotherapy (Ipilimumab and Nivolumab) vs Immediate Combination of Immunotherapy in Patients With Unresectable or Metastatic Melanoma With BRAF V600 Mutation : an EORTC Randomized Phase II Study (EBIN)
-
CLINICAL_TRIALS study record update · 2025-06-29A Phase II Trial of PD-L1 Therapy Combined With Anti-VEGF Therapy in Unresectable or Metastatic Melanoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-05-02Phase I Study of Vemurafenib Combined With Whole Brain Radiation Therapy (WBRT) or Radiosurgery (SRS) for Melanoma Patients With BRAF Mutation Presented With Brain Metastases
-
CLINICAL_TRIALS study record update · 2024-08-21A Phase I Trial of the mTOR Inhibitor RAD001 in Combination With VEGF Receptor Tyrosine Kinase Inhibitor PTK787/ZK 222584 in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2024-05-21A Phase 2 Study Using Stereotactic Ablative Radiation Therapy and Ipilimumab in Patients With Oligometastatic Melanoma
-
CLINICAL_TRIALS study record update · 2024-05-03An Open-Label Study of KW-2871 Administered With a Premedication Regimen in Patients With Advanced Stage IV Melanoma
-
CLINICAL_TRIALS study record update · 2024-03-04Phase I/II Study of HLA-Matched Peripheral Blood Mobilized Hematopoietic Progenitor Cell Transplantation Followed by Allogeneic T-cell Infusion as Adoptive Immunotherapy in Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2024-03-04Phase II Study of DNA Encoding the gp100 Antigen Alone or in Combination With Interleukin-2 in Patients With Recurrent Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2024-03-04Phase II Study of Flt3 Ligand Alone or in Combination With Melanoma Peptide Immunization in Patients With Metastatic Melanoma or Renal Cell Cancer
-
CLINICAL_TRIALS study record update · 2024-03-04Phase II Randomized Study of CD34+ Derived or Peripheral Monocyte Derived Dendritic Cells Pulsed With MART-1 and gp100 Melanoma Antigens in Patients With High Risk Stage III or Completely Resected Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2023-12-26Psilocybin-assisted Psychotherapy in the Management of Anxiety Associated With Stage IV Melanoma.
-
CLINICAL_TRIALS study record update · 2023-10-23Understanding Patient Engagement Trends in Stage IV Melanoma Clinical Trials
-
CLINICAL_TRIALS study record update · 2023-10-23Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer
-
CLINICAL_TRIALS study record update · 2023-09-26TraMel-WT: A Stratified Dual-stratum Open-label Two-stage Phase 2 Trial of Trametinib in Patients With Advanced Pretreated BRAFV600 Wild-type Melanoma
-
CLINICAL_TRIALS study record update · 2023-06-18A Phase II Single Arm Study of High-Dose IL-2 and Ipilimumab in Patients With Unresectable Stage III and Stage IV Melanoma
-
CLINICAL_TRIALS study record update · 2023-05-22Copy of A Phase II Trial of Pembrolizumab (Anti PD-1) Therapy Combined With Sargramostim (GM-CSF) in Unresectable or Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2023-03-02Pembrolizumab and All-Trans Retinoic Acid in Combination Treatment of Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2022-12-06A Pilot Study of Beta-Blockers in Patients With Advanced Cancer
-
CLINICAL_TRIALS study record update · 2022-11-15Phase I/II Study To Evaluate The Safety Of Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cell Clones Following CD25 Lymphodepletion For Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2022-05-03A Phase 1 Multi-Center Dose-Escalation Study of the Safety, Tolerability and Early Efficacy of TBX-3400 in Patients With Stage III and IV Melanoma Resistant or Refractory to Immune Checkpoint Inhibitors
-
CLINICAL_TRIALS study record update · 2022-04-13A Phase II Open-Label, Multicenter Study of Denileukin Diftitox in Patients With Stage IIIC and Stage IV Melanoma
-
CLINICAL_TRIALS study record update · 2021-03-24A Pilot Study, Single-Center, Open-Label, Sequentional Immuno Apheresis Plasma Volume Escalation Cohort Study of Reduction of Soluble Tumor Necrosis Factor Receptors 1 and 2 (sTNFR1/2) With or Without Nivolumab in Patients With Inoperable or Metastatic Solid Tumors